Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Continuous multi-channel intravascular monitoring of the effects of dopamine and dobutamine on plasma potassium in dogs.
-
Publication Type:Journal article
-
Publication Sub Type:Journal Article
-
Authors:Drake HF, Smith M, Corfield DR, Treasure T
-
Publication date:1989
-
Pagination:446, 451
-
Journal:Intensive Care Med
-
Volume:15
-
Issue:7
-
Status:Published
-
Country:United States
-
Print ISSN:0342-4642
-
Language:eng
-
Keywords:Animals, Aorta, Dobutamine, Dogs, Dopamine, Electrodes, Implanted, Hyperkalemia, Hypokalemia, Infusions, Intravenous, Monitoring, Physiologic, Vena Cava, Inferior
-
Author URL:
Abstract
The effects of dopamine and dobutamine on plasma potassium were investigated in dogs using continuous, multi-channel, intravascular ion-selective potassium electrodes situated in the aorta and abdominal and thoracic inferior vena cavae. Doses of 10 and 30 micrograms kg-1 min-1 of each drug were used, and the effects on potassium compared with isoprenaline 0.07 and 0.2 microgram kg-1 min-1. Both the drugs caused a biphasic pattern of potassium change consisting of an initial small rise in the potassium level, followed by a sustained period of hypokalaemia. The changes were greater with the higher dose of each drug compared with the lower dose, but there were no significant differences between the drugs. Comparison of the potassium changes between the three vascular sites studied suggested that the rise in potassium may be a result of release of the ion from the liver, and that the liver may also be the principle site of potassium uptake during the hypokalaemic phase.
› More search options
UCL Researchers